Table of Content

Executive Summary
1 Market Definition
1.1 Radiation Therapy
1.2 Phantoms
1.3 Phantoms in Quality Assurance

2 Scope of the Report

3 Research Methodology
3.1 Research Methodology
3.1.1 Data Triangulation
3.1.2 Primary Data Sources
3.1.3 Secondary Data Sources
3.1.4 Bottom-up Approach
3.1.5 Assumptions and Limitations

4 Industry Insights
4.1 Technological Trends in Radiation Therapy
4.2 Complete Workflow of Imaging Techniques
4.2.1 QA Associated with IMRT
4.2.2 QA Associated with Stereotactic Radiosurgery
4.3 Regulatory Framework
4.3.1 Regulatory Framework in the America
4.3.1.1 Food and Drug Administration (FDA)
4.3.1.2 United States Department of Health and Human Services (HHS)
4.3.1.3 The American Society for Radiation Oncology (ASTRO)
4.3.1.4 American Medical Association (AMA)
4.3.2 Regulatory Framework in Europe
4.3.2.1 European Commission (EC)
4.3.3 Regulatory Framework in Asia-Pacific
4.4 Patent Analysis
4.5 Value Chain Analysis

5 Competitive Landscape
5.1 Market Share Analysis
5.2 Key Developments and Strategies
5.2.1 Collaborations and Partnerships
5.2.2 Product Launches
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion

6 Market Dynamics
6.1 Market Drivers
6.1.1 Enhanced Patient and Machine Quality Assurance in Radiation Therapy
6.1.2 Use of Tissue Equivalent Phantoms
6.1.3 Rising Burden of Cancer
6.2 Market Challenges/Restraints
6.2.1 Cost of Phantoms in Emerging Markets
6.2.2 Increased Market Competition
6.2.3 Skill Set Gap

7 Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Technology)
7.1 Assumptions and Limitations
7.2 Overview
7.3 Linear Accelerators
7.4 Cobalt-60
7.5 High-Dose Radiation
7.6 Low-Dose Radiation

8 Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Therapy)
8.1 Assumptions and Limitations
8.2 Overview
8.3 External Radiation Therapy
8.3.1 Photon Beam Radiation Therapy
8.3.2 Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
8.3.3 Volumetric Modulated Arc Therapy (VMAT)
8.3.4 Image Guided Radiation Therapy (IGRT)
8.3.5 Stereotactic Radiation Therapy
8.3.6 Intraoperative Radiotherapy (IORT)
8.3.7 Proton Beam Therapy
8.3.8 Neutron Beam Therapy
8.4 Internal Radiation Therapy or Brachytherapy

9 Global Radiation Therapy Quality Assurance Phantoms Market (by Region)
9.1 Assumptions and Limitations
9.2 Overview
9.2.1 Analysis of Growth Potential of Different Countries
9.3 North America
9.3.1 U.S.
9.3.2 Canada
9.4 Europe
9.4.1 Germany
9.4.2 France
9.4.3 Russia
9.4.4 Italy
9.4.5 U.K.
9.4.6 Spain
9.4.7 Rest-of-Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Australia
9.5.5 South Korea
9.5.6 Rest-of-Asia-Pacific
9.6 Rest-of-the-World
9.6.1 Latin America
9.6.1.1 Brazil
9.6.1.2 Mexico
9.6.1.3 Rest-of-Latin-America
9.6.2 Middle East and Africa
9.6.2.1 Saudi Arabia
9.6.2.2 Egypt
9.6.2.3 South Africa

10 Company Profiles
10.1 Overview
10.2 Computerized Imaging Reference Systems, Inc.
10.2.1 Company Overview
10.2.2 Role of Computerized Imaging Reference Systems, Inc. in the Global Radiation Therapy QA Phantoms Market
10.2.2.1 Product Mapping
10.2.2.2 Recent Developments
10.2.2.3 Mergers and Acquisitions
10.2.3 SWOT Analysis
10.3 Fluke Biomedical
10.3.1 Company Overview
10.3.2 Role of Fluke Biomedical in the Global Radiation Therapy QA Phantoms Market
10.3.2.1 Product Mapping
10.3.2.2 Recent Developments
10.3.2.3 Mergers and Acquisitions
10.3.3 SWOT Analysis
10.4 IBA Dosimetry
10.4.1 Company Overview
10.4.2 Role of IBA Dosimetry in the Global Radiation Therapy QA Phantoms Market
10.4.2.1 Product Mapping
10.4.2.2 Recent Developments
10.4.3 Financials
10.4.4 SWOT Analysis
10.5 Modus Medical Devices Inc.
10.5.1 Company Overview
10.5.2 Role of Modus Medical Devices Inc. in the Global Radiation Therapy QA Phantoms Market
10.5.2.1 Product Mapping
10.5.3 SWOT Analysis
10.6 PTW Freiburg GmbH
10.6.1 Company Overview
10.6.2 Role of PTW Freiburg GmbH in the Global Radiation Therapy QA Phantoms Market
10.6.2.1 Product Mapping
10.6.3 SWOT Analysis
10.7 Standard Imaging Inc.
10.7.1 Company Overview
10.7.2 Role of Standard Imaging Inc. in the Global Radiation Therapy QA Phantoms Market
10.7.2.1 Product Mapping
10.7.2.2 Recent Developments
10.7.3 SWOT Analysis
10.8 Sun Nuclear Corporation
10.8.1 Company Overview
10.8.2 Role of Sun Nuclear Corporation in the Global Radiation Therapy QA Phantoms Market
10.8.2.1 Product Mapping
10.8.2.2 Recent Developments
10.8.3 SWOT Analysis
10.9 The Phantom Laboratory, Inc.
10.9.1 Company Overview
10.9.2 Role of The Phantom Laboratory, Inc. in the Global Radiation Therapy QA Phantoms Market
10.9.2.1 Product Mapping
10.9.3 SWOT Analysis
 



List of Tables



Table 1: Regional Data for Cancer Patients, Global, 2018
Table 4.1: Regulatory Authorities/Associations/Consortiums for Medical Devices in Americas
Table 4.2: Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
Table 4.3: Regulatory Authorities/Associations/Consortiums for Medical Devices in Asia-Pacific
Table 4.4: Patent Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market (by Assignee)
Table 5.1: Competitors’ Snapshot for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
Table 6.1: Planning Process in Radiation Therapy QA
Table 8.1: Global Radiation Therapy QA Phantoms Market (by Volume: by Therapy), 2019-2024
Table 10.1: Product Mapping: Computerized Imaging Reference Systems, Inc.
Table 10.2: Product Mapping: Fluke Biomedical
Table 10.3: Product Mapping: IBA Dosimetry
Table 10.4: Product Mapping: Modus Medical Devices Inc.
Table 10.5: Product Mapping: PTW Freiburg GmbH
Table 10.6: Product Mapping: Standard Imaging Inc.
Table 10.7: Product Mapping: Sun Nuclear Corporation
Table 10.8: Product Mapping: The Phantom Laboratory Inc.

List of Figures



Figure 1: Number of New Cancer Cases, Global, 2018
Figure 2: Impact Analysis of Market Drivers and Challenges
Figure 3: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
Figure 4: Radiation Therapy Quality Assurance Phantoms Market, Growth Potential, by Country, 2019-2024
Figure 5: Global Radiation Therapy QA Phantoms Market (by Region), 2019-2024
Figure 6: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
Figure 2.1: Global Radiation Therapy Quality Assurance Phantoms Market: Segmentation
Figure 3.1: Radiation Therapy Quality Assurance Phantoms Market Research Methodology
Figure 3.2: Data Triangulation
Figure 3.3: Primary Research
Figure 3.4: Secondary Research
Figure 3.5: Bottom-Up Approach (Segment-wise Analysis)
Figure 3.6: Assumptions and Limitations
Figure 4.1: Value Analysis of Radiation Therapy Quality Assurance Phantom Market
Figure 5.1: Competitive Landscape- Global Radiation Therapy Quality Assurance Phantoms Market
Figure 5.2: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
Figure 5.3: Share of Key Developments and Strategies, January 2013-September 2019
Figure 5.4: Collaborations, and Partnerships Share (by Companies), January 2013-September 2019
Figure 5.5: Product Launches Share (by Companies), January 2013-September 2019
Figure 5.7: Business Expansion Share (by Companies), January 2013-September 2019
Figure 6.1: Impact Analysis of Market Drivers and Challenges, 2019-2024
Figure 6.2: Number of New Cancer Cases (Global), 2018
Figure 7.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Technology, Market Share, 2018
Figure 7.2: Global Radiation Therapy Equipment Installations (by Region), 2018
Figure 7.3: Linear Accelerators in Radiation QA Phantoms Market (by Value), 2019-2024
Figure 7.4: Linear Accelerators in Radiation QA Phantoms Market (by Volume), 2019-2024
Figure 7.5: Cobalt-60 in Radiation QA Phantoms Market (by Value), 2019-2024
Figure 7.6: Cobalt-60 in Radiation QA Phantoms Market (by Volume), 2019-2024
Figure 7.7: High-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
Figure 7.8: High-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
Figure 7.9: Low-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
Figure 7.10: Low-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
Figure 8.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2018
Figure 8.2: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2024
Figure 8.3: Photon Beam Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
Figure 8.4: Advanced 3D- Conformal Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
Figure 8.5: Volumetric Modulated Arc Therapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 8.6: Image-Guided Radiation Therapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 8.7: Stereotactic Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
Figure 8.8: Intraoperative Radiotherapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 8.9: Proton Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 8.10: Neutron Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 8.11: Brachytherapy in Global Radiation QA Phantoms Market, 2019-2024
Figure 9.1: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
Figure 9.2: North America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.3: North America- Market Dynamics
Figure 9.4: Number of New Cancer Cases in North America, 2018
Figure 9.5: North America: Number of Phantoms (by Country), 2018-2024
Figure 9.6: Number of New Cancer Cases in U.S., 2018
Figure 9.7: U.S.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.8: Number of New Cancer Cases in Canada, 2018
Figure 9.9: Canada: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.10: Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.11: Europe: Radiation Therapy Quality Assurance Phantoms, Market Share (by Country), 2018
Figure 9.12: Europe: Market Dynamics
Figure 9.13: Number of New Cancer Cases in Europe, 2018
Figure 9.14: Europe: Number of Phantoms (by Country), 2018-2024
Figure 9.15: Number of New Cancer Cases in Germany, 2018
Figure 9.16: Germany: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.17: Number of New Cancer Cases in France, 2018
Figure 9.18: France: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.19: Number of New Cancer Cases in Russia, 2018
Figure 9.20: Russia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.21: Number of New Cancer Cases in Italy, 2018
Figure 9.22: Italy: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.23: Number of New Cancer Cases in the U.K., 2018
Figure 9.24: U.K.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.25: Number of New Cancer Cases in Spain, 2018
Figure 9.26: Spain: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.27: Rest-of-Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.28: Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.29: Asia-Pacific: Number of Phantoms (by Country), 2018-2024
Figure 9.30: Asia-Pacific: Market Dynamics
Figure 9.31: Number of New Cancer Cases in Asia, 2018
Figure 9.32: Number of New Cancer Cases in China, 2018
Figure 9.33: China: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.34: Number of New Cancer Cases in Japan, 2018
Figure 9.35: Japan: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.36: Number of New Cancer Cases in India, 2018
Figure 9.37: India: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.38: Number of New Cancer Cases in Australia, 2018
Figure 9.39: Australia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.40: Number of New Cancer Cases in South Korea, 2018
Figure 9.41: South Korea: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.42: Rest-of-Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.43: Rest-of-the-World: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.44: Rest-of-the-World: Number of Phantoms (by Region), 2018-2024
Figure 9.45: Latin America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.46: Latin America: Number of Phantoms (by Country), 2018-2024
Figure 9.47: Number of New Cancer Cases in Brazil, 2018
Figure 9.48: Brazil: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.49: Number of New Cancer Cases in Mexico, 2018
Figure 9.50: Mexico: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.51: Rest-of-Latin-America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.52: Middle East and Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.53: Middle East: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.54: Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
Figure 9.55: Number of New Cancer Cases in Saudi Arabia, 2018
Figure 9.56: Number of New Cancer Cases in Egypt, 2018
Figure 9.57: Number of New Cancer Cases in South Africa, 2018
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: Modality Supported by Phantoms of CIRS, Inc.
Figure 10.3: Computerized Imaging Reference Systems, Inc.: SWOT Analysis
Figure 10.4: Modalities Supported by Phantoms of Fluke Biomedical
Figure 10.5: Fluke Biomedical: SWOT Analysis
Figure 10.6: Modalities Supported by Phantoms of IBA Dosimetry
Figure 10.7: IBA Dosimetry: Overall Financials, 2017-2018
Figure 10.8: IBA Dosimetry: SWOT Analysis
Figure 10.9: Modalities Supported by Phantoms of Modus Medical Devices Inc.
Figure 10.10: Modus Medical Devices Inc.: SWOT Analysis
Figure 10.11: Modalities Supported by Phantoms of PTW Freiburg GmbH
Figure 10.12: PTW Freiburg GmbH: SWOT Analysis
Figure 10.13: Modalities Supported by Phantoms of Standard Imaging Inc.
Figure 10.14: Standard Imaging Inc.: SWOT Analysis
Figure 10.15: Modalities Supported by Phantoms of Sun Nuclear Corporation
Figure 10.16: Sun Nuclear Corporation: SWOT Analysis
Figure 10.17: Modalities Supported by Phantoms of The Phantom Laboratory Inc.
Figure 10.18: The Phantom Laboratory, Inc.: SWOT Analysis